Tsay Woei, Shen Ming-Ching
Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Am J Hematol. 2004 May;76(1):8-13. doi: 10.1002/ajh.20043.
We analyzed the genetic defects of 21 unrelated patients with venous thrombosis in whom hereditary protein C deficiency was diagnosed. Eleven mutations were detected in 18 families, while no mutation was detectable in the other three families. Among these mutations, a common genetic mutation of protein C (PROC) gene recurred in 43% (nine propositi from these 21 families). This C6152T mutation at exon 7 resulted in a missense mutation, Arg147Trp (R147W). Each propositus or family carrier had another specific polymorphism T66C at exon 2, which did not change the proline at position (-21). The haplotype analysis strongly suggested a founder effect. The first thrombotic attack was significantly younger in patients with multiple genetic defects or combined with other risk factors than those without precipitating factors. We further studied the prevalence rate of R147W mutations in normal populations through PCR amplification and dot hybridization. Three different cohorts got similar results. The prevalence rate of R147W in health controls is 0.85% [95% confidence interval (CI) 0.35-1.35]. Analysis of plasma protein C levels of all patients or carriers suggested that R147W was a type II deficiency. The odds ratio of thrombosis of R147W is 5.1 (95% CI 1.7-14.8). Taken together, R147W mutation is a significant thrombotic risk factor and is the most common defect of PROC gene in Taiwanese patients with protein C deficiency. This finding is important for screening thrombophilic families in Chinese populations.
我们分析了21例被诊断为遗传性蛋白C缺乏症的非亲缘关系静脉血栓患者的基因缺陷。在18个家族中检测到11种突变,而其他3个家族未检测到突变。在这些突变中,蛋白C(PROC)基因的一种常见基因突变在43%(21个家族中的9名先证者)的家族中反复出现。该外显子7上的C6152T突变导致错义突变,即Arg147Trp(R147W)。每个先证者或家族携带者在外显子2处还有另一种特定的多态性T66C,该多态性不会改变(-21)位的脯氨酸。单倍型分析强烈提示存在奠基者效应。与没有促发因素的患者相比,具有多种基因缺陷或合并其他危险因素的患者首次血栓形成发作的年龄明显更小。我们通过PCR扩增和点杂交进一步研究了正常人群中R147W突变的患病率。三个不同队列得到了相似的结果。健康对照人群中R147W的患病率为0.85%[95%置信区间(CI)0.35 - 1.35]。对所有患者或携带者的血浆蛋白C水平分析表明,R147W属于II型缺乏。R147W发生血栓形成的优势比为5.1(95%CI 1.7 - 14.8)。综上所述,R147W突变是一个重要的血栓形成危险因素,并且是台湾蛋白C缺乏症患者中PROC基因最常见的缺陷。这一发现对于筛查中国人群中的易栓家族具有重要意义。